Compare NWGL & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NWGL | POM |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | Macau | China |
| Employees | N/A | 165 |
| Industry | | Other Specialty Stores |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1M | 11.3M |
| IPO Year | 2022 | N/A |
| Metric | NWGL | POM |
|---|---|---|
| Price | $0.28 | $0.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 55.2K |
| Earning Date | 05-21-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.19 | $0.06 |
| 52 Week High | $1.82 | $6.43 |
| Indicator | NWGL | POM |
|---|---|---|
| Relative Strength Index (RSI) | 44.00 | 40.50 |
| Support Level | $0.19 | $0.63 |
| Resistance Level | $0.31 | $1.78 |
| Average True Range (ATR) | 0.05 | 0.19 |
| MACD | 0.01 | -0.08 |
| Stochastic Oscillator | 23.66 | 15.98 |
CL Workshop Group Ltd, formerly Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.